AU7091296A - Polypeptides and their use in treatment and prophylaxis of auto-immune disease - Google Patents

Polypeptides and their use in treatment and prophylaxis of auto-immune disease

Info

Publication number
AU7091296A
AU7091296A AU70912/96A AU7091296A AU7091296A AU 7091296 A AU7091296 A AU 7091296A AU 70912/96 A AU70912/96 A AU 70912/96A AU 7091296 A AU7091296 A AU 7091296A AU 7091296 A AU7091296 A AU 7091296A
Authority
AU
Australia
Prior art keywords
prophylaxis
polypeptides
auto
treatment
immune disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70912/96A
Inventor
Christopher John Elson
James Stephen Thompson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Holding Ltd
Original Assignee
Peptide Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptide Therapeutics Ltd filed Critical Peptide Therapeutics Ltd
Publication of AU7091296A publication Critical patent/AU7091296A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU70912/96A 1995-09-27 1996-09-26 Polypeptides and their use in treatment and prophylaxis of auto-immune disease Abandoned AU7091296A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9519737 1995-09-27
GBGB9519737.2A GB9519737D0 (en) 1995-09-27 1995-09-27 Polypeptides and their use in treatment and prophylaxis of auto-immune
PCT/GB1996/002382 WO1997011966A1 (en) 1995-09-27 1996-09-26 Polypeptides and their use in treatment and prophylaxis of auto-immune disease

Publications (1)

Publication Number Publication Date
AU7091296A true AU7091296A (en) 1997-04-17

Family

ID=10781379

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70912/96A Abandoned AU7091296A (en) 1995-09-27 1996-09-26 Polypeptides and their use in treatment and prophylaxis of auto-immune disease

Country Status (3)

Country Link
AU (1) AU7091296A (en)
GB (1) GB9519737D0 (en)
WO (1) WO1997011966A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0947524A1 (en) * 1998-03-30 1999-10-06 Upither B.V. Novel peptides for the treatment of autoimmune diseases
AU7033400A (en) * 1999-08-30 2001-03-26 Jehad Mikhaiel Charo Induction of cytotoxic t lymphocyte response by hla class ia restricted epitopesof mycobacterial heat shock protein 65
US7608683B2 (en) 2000-08-09 2009-10-27 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
US6989146B2 (en) 2000-08-09 2006-01-24 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
EP1652856A1 (en) * 2000-08-09 2006-05-03 The Regents of The University of California San Diego Stress proteins-derived peptides and method of use thereof
EP1575479A4 (en) 2002-01-31 2006-10-25 Develogen Israel Ltd Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
CU23504A1 (en) 2004-09-24 2010-04-13 Ct Ingenieria Genetica Biotech PEPTIDES AND DERIVATIVES APL TYPE OF HSP60 AND PHARMACEUTICAL COMPOSITIONS
WO2006072946A2 (en) 2005-01-04 2006-07-13 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Hsp60, hsp60 peptides and t cell vaccines for immunomodulation
US10703784B2 (en) * 2011-09-30 2020-07-07 La Jolla Institute For Allergy And Immunology Antigens and epitopes derived from Mycobacterium tuberculosis
CN112724238B (en) * 2021-01-21 2022-05-31 浙江辉肽生命健康科技有限公司 Bioactive peptide with amino acid structure FREGTTPKPK, and preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989012455A1 (en) * 1988-06-15 1989-12-28 Whitehead Institute For Biomedical Research Stress proteins and uses therefor
DE69429723T2 (en) * 1993-06-04 2002-09-26 Whitehead Biomedical Inst STRESS PROTEINS AND THEIR USE
DK0751957T3 (en) * 1994-03-21 2004-06-01 Univ Utrecht Peptide Fragments of Microbial Stress Proteins and Pharmaceutical Composition Made Therefrom for the Treatment and Prevention of Inflammatory Diseases
US5958416A (en) * 1994-12-16 1999-09-28 Regents Of The University Of Minnesota Heat shock protein peptides and methods for modulating autoimmune central nervous system disease

Also Published As

Publication number Publication date
WO1997011966A1 (en) 1997-04-03
GB9519737D0 (en) 1995-11-29

Similar Documents

Publication Publication Date Title
AU5687896A (en) Use of alpha 1L-agonists in the treatment of incontinence
AU7230196A (en) Pskh-1 ribozymes and uses in disease treatment
AU4054297A (en) Manipulations of nitrosative and oxidatives stress in the treatment of disease
AU7623096A (en) Use of epinastine in the treatment of pain
IL117993A0 (en) Modified anti-icam-1 antibodies and their use in the treatment of inflammation
IL122216A0 (en) Dolastatin derivatives their preparation and use
AU5360796A (en) Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
AU3571095A (en) Polypeptides and their use in treatment and prophylaxis of auto-immune disease
HUP9603373A3 (en) Cosmetic composition for artificial tanning and its use
AU7091296A (en) Polypeptides and their use in treatment and prophylaxis of auto-immune disease
AU3099997A (en) The use of tcet in the prophylaxis and treatment of allergies
EP0831793A4 (en) Protein particles for therapeutic and diagnostic use
AU5681694A (en) Use of thioureleylenes and thiabendazole in autoimmune diseases
AU8717791A (en) Replication initiator protein complex and methods of use thereof
AU5674496A (en) Murine and human box-dependent myc-interacting protein (bin1 ) and uses therefor
AU6761294A (en) Cell surface protein expressed on human cortical thymocyte and their use
AU4762893A (en) Hla-dr3 blocking peptides and their use in the treatment of hla-dr3 associated autoimmune diseases.
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU5014896A (en) Antibody to human betacellulin and use thereof
AU4137596A (en) Method for the treatment of periodontal disease and a pharmaceutical composition useful in said method
AU3752189A (en) Pharmaceutical compositions and use thereof in treating inflammation
IL123156A0 (en) Benzenesulphonamide derivatives their preparation and their application in therapy
AU1031397A (en) Human peptide circulating in the blood and possessing insulinotropic properties
IL116658A0 (en) Peptides their preparation and use